<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR524.html">Part 524
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 524.1580  Nitrofurazone topical dosage forms.

Sec. 524.1580a  Nitrofurazone ointment.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. The drug contains 0.2 percent nitrofurazone in a water-soluble base.</p><p class="depth0"><em>(b)</em> Sponsors. See sponsors in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(1)</em> See Nos. 054628, 054925, 058005, 059051, and 061623 for use on dogs, cats, or horses.</p><p class="depth0"><em>(2)</em> See No. 017135 for use on dogs and horses.</p><p class="depth0"><em>(3)</em> See Nos. 017153 and 058829 for use on horses.</p><p class="depth0"><em>(c)</em> [Reserved]</p><p class="depth0"><em>(d)</em> Conditions of use--(1) Amount. Apply directly on the lesion with a spatula or first place on a piece of gauze. The preparation should remain on the lesion for at least 24 hours. Use of a bandage is optional.</p><p class="depth0"><em>(2)</em> Indications for use. For prevention or treatment of surface bacterial infections of wounds, burns, and cutaneous ulcers of dogs, cats, or horses.</p><p class="depth0"><em>(3)</em> Limitations. For use only on dogs, cats, and horses. Do not use in horses intended for human consumption. Federal law prohibits the use of this product in food-producing animals. In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness, irritation, or swelling persists or increases, discontinue use; consult veterinarian.
[46 FR 43402, June 27, 1980. Redesignated at 79 FR 10971, Feb. 27, 2014]</p><p class="depth0">Editorial Note: For Federal Register citations affecting Sec. 524.1580a, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at www.fdsys.gov.


Sec. 524.1580b  Nitrofurazone soluble powder.</p><p class="depth0"><em>(a)</em> Specifications. The drug contains 0.2 percent nitrofurazone in a water-soluble base.</p><p class="depth0"><em>(b)</em> Sponsor. See Nos. 054628 and 059051 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use--(1) Amount. Apply several times daily to the lesion or affected area from the plastic squeeze bottle.</p><p class="depth0"><em>(2)</em> Indications for use. For prevention or treatment of surface bacterial infections of wounds, burns, skin ulcers, and abscesses after incision.</p><p class="depth0"><em>(3)</em> Limitations. In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness, irritation, or swelling persists or increases, discontinue use; consult veterinarian. For use only on dogs, cats, and horses (not for food use).
[45 FR 43402, June 27, 1980, as amended at 47 FR 43368, Oct. 1, 1982; 48 FR 28984, June 24, 1983; 53 FR 40728, Oct. 18, 1988; 54 FR 30542, July 21, 1989; 56 FR 50653, Oct. 8, 1991; 59 FR 33197, June 28, 1994; 60 FR 55659, Nov. 2, 1995; 62 FR 35077, June 30, 1997; 76 FR 17778, Mar. 31, 2011; 78 FR 21060, Apr. 9, 2013. Redesignated at 79 FR 10971, Feb. 27, 2014, as amended at 79 FR 64117, Oct. 28, 2014]


Sec. 524.1580c  Nitrofurazone and butacaine ointment.</p><p class="depth0"><em>(a)</em> Specifications. The drug contains 0.2 percent nitrofurazone and 0.5 percent butacaine sulfate in a water-soluble base.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 054925 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use--(1) Indications for use. For prevention or treatment of surface bacterial infections of ears, wounds, burns, and cutaneous ulcers of dogs, cats, and horses.</p><p class="depth0"><em>(2)</em> Limitations. Apply directly on the lesion with a spatula or first place on a piece of gauze. Use of a bandage is optional. The preparation should remain on the lesion for at least 24 hours. The dressing may be changed several times daily or left on the lesion for a longer period. For use only on dogs, cats, and horses (not for food use). In case of deep or puncture wounds or serious burns, use only as recommended by a veterinarian. If redness, irritation, or swelling persists or increases, discontinue use; consult veterinarian.
[49 FR 9417, Mar. 13, 1984, as amended at 71 FR 13542, Mar. 16, 2006. Redesignated at 79 FR 10971, Feb. 27, 2014; 79 FR 10971, Feb. 27, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
